baricitinib vs upadacitinib atopic dermatitis

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
baricitinib vs upadacitinib atopic dermatitis	1.5	0.8	9575	69	45
baricitinib	0.28	0.5	5973	4	11
vs	0.89	0.9	5982	8	2
upadacitinib	0.11	1	5883	63	12
atopic	1.61	0.1	9839	8	6
dermatitis	1.48	0.8	5679	94	10

Keyword	CPC	PCC	Volume	Score
baricitinib vs upadacitinib atopic dermatitis	1.24	0.3	3399	41
baricitinib for atopic dermatitis	1.63	0.5	7651	25
baricitinib atopic dermatitis fda	0.53	0.9	157	11
baricitinib fda approval atopic dermatitis	0.28	1	5051	30
upadacitinib for atopic dermatitis	1.64	0.4	2547	13
upadacitinib atopic dermatitis approval	0.01	0.7	8970	81
upadacitinib atopic dermatitis phase 3	0.35	0.2	1996	51
upadacitinib atopic dermatitis fda approval	1.84	0.1	9024	10
lilly baricitinib atopic dermatitis	0.85	0.6	2686	61
off-label use of baricitinib in dermatology	0.31	0.7	8699	75
baricitinib fda pharmacology review	0.7	0.3	3529	87
baricitinib and bacterial infection	0.95	0.1	2585	1
baricitinib fact sheet for patients	0.65	0.5	690	79
tofacitinib in atopic dermatitis	0.28	0.7	4330	56
baricitinib juvenile idiopathic arthritis	0.43	0.5	71	71
baricitinib for rheumatoid arthritis	0.95	0.1	185	80
baricitinib patient information leaflet	1.4	0.1	3002	9
baricitinib eua fact sheet	1.75	0.7	8913	97
baricitinib fda approval rheumatoid arthritis	0.35	0.7	7110	8
baricitinib for alopecia areata	1.01	0.1	8812	1
can baricitinib be crushed	0.76	0.2	5767	58
baricitinib public assessment report	1.91	0.7	4481	94
baricitinib type 1 diabetes	0.44	0.7	414	22